CPH Proteomics ApS

APSDissolvedAdvertising protection

CVR 38267744Brovænget 29, 2700 BrønshøjResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2016 · 9 years old— employees

Overview

CPH Proteomics ApS is a Danish APS based in Brønshøj, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2016, the company reported revenue of DKK 247.0k in its latest annual filing.

Revenue 2024

247K DKK

+1% vs 2023

EBITDA margin

91.1 %

−4% vs 2023

Net profit 2024

174.9K DKK

-4% vs 2023

Key ratios

See full ratios →

64.7 %

Average

Around the average of companies in the same industry

20202024

2.8×

Strong

Among the 40% highest rated companies in the industry

20202024

35.3 %

Very strong

Among the 20% highest rated companies in the industry

20202024

EBITDA — year on year

DKK thousands

Key figures

Annual report 2024

Revenue	247K DKK	+1%
EBITDA	225K DKK	-4%
Net profit	174.9K DKK	-4%
Total assets	495.7K DKK	-12%
Equity	320.8K DKK	-16%
Employees	—	—

Contact

Address

Brovænget 29, 2700 Brønshøj

Advertising protection

Active — opted out of marketing use

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Financial development

In its most recent annual report (2024), CPH Proteomics ApS reported revenue of DKK 247.0k, an increase of 1% on the year before. The figures on this page draw on 5 annual filings covering 2020 to 2024. The bottom line showed a net profit of DKK 174.9k, and the EBITDA margin stood at 91.1%.

At the end of 2024, equity financed 64.7% of the balance sheet, and current assets covered short-term debt 2.8 times. CPH Proteomics ApS is one of 2 companies registered under Research and experimental development on natural sciences and engineering in Denmark.

Financials

Revenue

DKK thousands

EBITDA

DKK thousands

Income statement

DKK thousands

Item	2024	2023	2022	2021	2020
Revenue	247	245	219	200	164
Staff expenses	-13	-5	-0	-0	-0
EBITDA	225	235	219	200	164
Depreciation & amort.	-0	-0	-0	-6	-7
EBIT	225	235	219	194	156
Net financials	-2	-3	-5	-2	-1
Profit before tax	223	233	214	192	156
Tax	48	50	-0	-0	-0
Net profit	175	182	214	192	156

Get a credit rating – not just the numbers

Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.

See the credit rating

Balance sheet

DKK thousands

Item	2024	2023	2022	2021	2020
Total assets	496	563	540	478	518
Equity	321	381	330	288	351
Long-term debt	0	0	0	0	0
Short-term debt	175	182	210	190	167
Total debt	175	182	210	190	167

Financial ratios

5-year trend

EBITDA margin

91.1 %

20202024

Equity ratio

64.7 %

Average

Around the average of companies in the same industry

20202024

Return on equity

54.5 %

Strong

Among the 30% highest rated companies in the industry

20202024

Net profit margin

70.8 %

Very strong

Among the 20% highest rated companies in the industry

20202024

Asset turnover

0.50×

Average

Around the average of companies in the same industry

20202024

Debt / equity

0.55×

Average

Around the average of companies in the same industry

20202024

Sector performance

27 of 28 ratios graded

28 financial ratios from the latest filing, each graded against companies in the same industry.

Profitability

Gross marginVery strong

Among the 20% highest rated companies in the industry

The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.

Operating marginVery strong

Among the 10% highest rated companies in the industry

EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.

Net profit marginVery strong

Among the 20% highest rated companies in the industry

The profit for the year as a share of revenue — the company's ability to turn revenue into profit.

Return on equity (ROE)Strong

Among the 30% highest rated companies in the industry

Net profit as a percentage of equity — the return the owners earned on their invested capital this year.

Return on assets (ROA)Very strong

Among the 20% highest rated companies in the industry

Net profit as a percentage of total assets — the return generated on the capital employed.

Return on net assets (RONA)Strong

Among the 30% highest rated companies in the industry

Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.

Basic earning power (BEP)Very strong

Among the 20% highest rated companies in the industry

EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.

Capacity ratioVery strong

Among the 10% highest rated companies in the industry

Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.

Liquidity

Current ratioStrong

Among the 40% highest rated companies in the industry

Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.

Quick ratioStrong

Among the 40% highest rated companies in the industry

Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.

Cash ratioVery strong

Among the 20% highest rated companies in the industry

Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.

Current assets to equityWeak

Among the 40% lowest rated companies in the industry

Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.

Fixed assets to long-term capitalVery strong

Among the 10% highest rated companies in the industry

Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.

Cash conversion ratioStrong

Among the 40% highest rated companies in the industry

Cash flow relative to profit — the ability to convert reported profits into accessible cash.

Debt & solvency

Solidity ratioAverage

Around the average of companies in the same industry

Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.

Debt ratioAverage

Around the average of companies in the same industry

Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.

Debt to equityAverage

Around the average of companies in the same industry

Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.

Liabilities to equityAverage

Around the average of companies in the same industry

Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.

Income to debtStrong

Among the 30% highest rated companies in the industry

Profit relative to debt — the ability to create earnings while operating with debt.

EBITDA to debtVery strong

Among the 20% highest rated companies in the industry

EBITDA relative to debt — how much operating earnings are available to service the debt.

Interest coverageVery strong

Among the 20% highest rated companies in the industry

The ability to pay the interest on the company's debt out of its earnings.

Interest rate on debtAverage

Around the average of companies in the same industry

Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.

Interest marginVery strong

Among the 20% highest rated companies in the industry

The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.

Efficiency & development

Asset turnoverAverage

Around the average of companies in the same industry

Revenue relative to total assets — the ability to generate revenue from the asset base.

Equity to contributed capitalAverage

Around the average of companies in the same industry

Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.

One-year change in equityWeak

Among the 30% lowest rated companies in the industry

The size of this year's increase or decrease in the company's equity.

One-year change in debtStrong

Among the 40% highest rated companies in the industry

The size of this year's increase or decrease in the company's debt.

Inventory turnoverNot rated

Cannot be graded — the figures this ratio builds on are not available in the latest filing.

Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.

Annual reports & filings

Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View PDF

People & ownership

Management

Actively employed in the business

Name	Role	Member since

Former (2)


JV Jesper Velgaard Olsen Chief Executive Officer	Chief Executive Officer	2016 – 2025
CF Casper Friis Management	Management	2016 – 2025

Board of directors

Non-executive oversight

No data on file.

Shareholders

Active legal owners

Shareholder	Type	Ownership	Votes	Registered
Jesper Velgaard Olsen	Individual	66.67–89.99%	66.67–89.99%	2016
Casper Friis	Individual	20–24.99%	20–24.99%	2016

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.

One in three Danish companies experiences fraud

Sound familiar? See how to strengthen your defences and catch suspicious changes in ownership and management in time.

See the fraud module

Related companies

Company hierarchy

No registered parent or subsidiaries

Board network connections

Board members of CPH Proteomics ApS also hold positions in 2 other companies.

Person	Role here	Other companies
Jesper Velgaard Olsen	Chief Executive Officer	2 companies

Frequently asked questions

What is the CVR number of CPH Proteomics ApS?

CPH Proteomics ApS is registered with CVR / Virk under CVR 38267744.

What is the revenue of CPH Proteomics ApS?

CPH Proteomics ApS reported revenue of DKK 247.0k in 2024.

Where is CPH Proteomics ApS headquartered?

CPH Proteomics ApS's registered address is Brovænget 29.